Pelthos Therapeutics Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-23.4M | $-25.1M | $-21.7M | $-16.2M | $-3.4M | $-2.0M | $-1.9M | $-1.7M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $278.0K | $469.0K | — | — | $0 | $0 | — | — |
| Amortization | $1.0M | $1.0M | $877.0K | $679.0K | $0 | $0 | — | — |
| Stock-Based Compensation | $2.8M | $1.9M | $1.8M | $2.8M | $413.0K | $486.0K | $530.0K | $517.5K |
| Net Cash from Operating Activities | $-7.7M | $-13.1M | $-6.3M | $-15.3M | $-447.0K | $-632.0K | $-670.0K | $-177.7K |
| Investing Activities | ||||||||
| Capital Expenditures | $2.0K | $194.0K | — | — | $0 | $0 | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-2.0K | $-194.0K | $-8.0M | $2.8M | $0 | $0 | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $0 | $27.5M | $18.0M | $26.7M | $375.0K | $250.0K | $-72.0K | $-972.0K |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-7.7M | $-13.3M | — | — | $-447.0K | $-632.0K | — | — |